Principal U.S. Small-Cap Multi-Factor ETF(PSC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PSC Principal U.S. Small-Cap Multi-Factor ETF

休市中 12-12 16:00:00 EST

59.10

-0.44

-0.74%

盘后59.10

+0.000.00%

16:10 EST

最高59.64	最低58.72	成交量10.55万
今开59.64	昨收59.54	日振幅1.55%
总市值15.39亿	流通市值15.39亿	总股本2,604万
成交额622.99万	换手率0.41%	流通股本2,604万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PSC","market":"US","secType":"STK","nameCN":"Principal U.S. Small-Cap Multi-Factor ETF","latestPrice":59.1,"timestamp":1765573200000,"preClose":59.5402,"halted":0,"volume":105542,"hourTrading":{"tag":"盘后","latestPrice":59.1,"preClose":59.1,"latestTime":"16:10 EST","volume":6,"amount":354.6,"timestamp":1765573803820},"delay":0,"floatShares":26040001,"shares":26040001,"eps":0.9,"marketStatus":"休市中","change":-0.4402,"latestTime":"12-12 16:00:00 EST","open":59.64,"high":59.64,"low":58.7201,"amount":6229943.7302,"amplitude":0.01545,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0.9,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":59.5402,"sharesOutstanding":26040001,"nav":58.689586,"aum":1548041364.34,"dividendRate":0.006548,"bidAskSpread":0.001778,"postHourTrading":{"tag":"盘后","latestPrice":59.1,"preClose":59.1,"latestTime":"16:10 EST","volume":6,"amount":354.6,"timestamp":1765573803820},"volumeRatio":0.7256538605534433},"requestUrl":"/m/hq/s/PSC/wiki","defaultTab":"wiki","newsList":[{"id":"2562205392","title":"君圣泰医药中期亏损大幅收窄 核心产品HTD1801新增适应症慢性肾病","url":"https://stock-news.laohu8.com/highlight/detail?id=2562205392","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562205392?lang=zh_cn&edition=full","pubTime":"2025-08-26 11:25","pubTimestamp":1756178745,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["02511","PSC.AU","PSC","BK1161","DM0.SI","BK7095","BK6053"],"gpt_icon":0},{"id":"2482460615","title":"高价收技术，持续巨亏！探秘天价股权激励背后的故事","url":"https://stock-news.laohu8.com/highlight/detail?id=2482460615","media":"星空财研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482460615?lang=zh_cn&edition=full","pubTime":"2024-11-07 17:25","pubTimestamp":1730971523,"startTime":"0","endTime":"0","summary":"大家都知道，国内在生物医药领域和头部国家们还有较大的差距，不过近些年来在不少细分领域，国内企业奋起直追，在极个别领域中取得了先发优势。来自北京的泽辉生物科技有限公司（简称：泽辉生物）就是一家拥有一定....","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OnBtud3hHHSUJfUN3MzlzrCLwW7FdFS0pgqjVhJ3JyiQEAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OnBtud3hHHSUJfUN3MzlzrCLwW7FdFS0pgqjVhJ3JyiQEAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241107A078B300","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241107A078B300","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1161","BK4139","PSC","02257","ARDS","02197"],"gpt_icon":0},{"id":"2479833780","title":"前宣武医院主任携泽辉生物赴港IPO，中国科学院成“关键先生”","url":"https://stock-news.laohu8.com/highlight/detail?id=2479833780","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479833780?lang=zh_cn&edition=full","pubTime":"2024-10-30 23:11","pubTimestamp":1730301095,"startTime":"0","endTime":"0","summary":"（图片来源：视觉中国）蓝鲸新闻10月30日讯（记者 邵雨婷）今年，干细胞市场风起云涌。日前，中国专家牵头制定了全球首个干细胞数据国际标准，中国首个干细胞创新药也申报上市，干细胞创新药有望在国内掀起商业化浪潮。2024年9月30日，专注研发干细胞创新药的泽辉生物科技有限公司（以下简称“泽辉生物”）向港交所递交招股...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/Osr--0F7KMiVZqv7CmBLJoBcYpoOlRHAkY9X3uyNNV89sAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/Osr--0F7KMiVZqv7CmBLJoBcYpoOlRHAkY9X3uyNNV89sAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241030A0AGTX00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241030A0AGTX00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["PSC"],"gpt_icon":0},{"id":"2475545893","title":"泽辉生物冲刺港交所，干细胞药物研发到哪一步了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2475545893","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475545893?lang=zh_cn&edition=full","pubTime":"2024-10-15 15:29","pubTimestamp":1728977365,"startTime":"0","endTime":"0","summary":"近日，泽辉生物向港交所递表，将申请主板挂牌上市。招股书显示，泽辉生物成立于2017年，专注于干细胞药物研发与生产。在细胞治疗备受资本与市场关注的当下，泽辉生物能从中分一杯羹吗？切中干细胞创新药风口泽辉生物招股书称，根据弗若斯特沙利文的资料，该公司是中国首批获得PSC（多能干细胞）来源细胞疗法新药临床试验申...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/O2_tz3t3jTP51uQLm9rAhUY_R9JVyq1jT3VLKL0Sj1sjoAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/O2_tz3t3jTP51uQLm9rAhUY_R9JVyq1jT3VLKL0Sj1sjoAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241015A05LDR00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241015A05LDR00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["PSC","BK1161","06978","BK1574"],"gpt_icon":0},{"id":"2472631825","title":"一图解码：泽辉生物冲击港股IPO 致力于PSC来源疗法研发 尚未商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2472631825","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472631825?lang=zh_cn&edition=full","pubTime":"2024-10-03 10:23","pubTimestamp":1727922203,"startTime":"0","endTime":"0","summary":"9月30日，泽辉生物向港交所递交了招股书，计划在主板挂牌上市；由中金公司担任独家保荐人。","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202410_1/0f81ceca-bcac-4e55-a9d7-3e7f516592df.jpg","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202410_1/0f81ceca-bcac-4e55-a9d7-3e7f516592df.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/66fe001bbde0b3449f7a10cc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["HSTECH","09633","YANG","PSC"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.principalfunds.com/fund/PSC","stockEarnings":[{"period":"1week","weight":0.0188},{"period":"1month","weight":0.0358},{"period":"3month","weight":0.0486},{"period":"6month","weight":0.1507},{"period":"1year","weight":0.0874},{"period":"ytd","weight":0.1527}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.021368},{"month":2,"riseRate":0.555556,"avgChangeRate":0.007268},{"month":3,"riseRate":0.555556,"avgChangeRate":-0.032339},{"month":4,"riseRate":0.555556,"avgChangeRate":0.010744},{"month":5,"riseRate":0.666667,"avgChangeRate":0.015187},{"month":6,"riseRate":0.777778,"avgChangeRate":0.018849},{"month":7,"riseRate":0.777778,"avgChangeRate":0.027652},{"month":8,"riseRate":0.444444,"avgChangeRate":0.000055},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.009541},{"month":10,"riseRate":0.5,"avgChangeRate":-0.005813},{"month":11,"riseRate":0.8,"avgChangeRate":0.056495},{"month":12,"riseRate":0.7,"avgChangeRate":0.002741}],"exchange":"NASDAQ","name":"Principal U.S. Small-Cap Multi-Factor ETF","nameEN":"Principal U.S. Small-Cap Multi-Factor ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Principal U.S. Small-Cap Multi-Factor ETF(PSC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Principal U.S. Small-Cap Multi-Factor ETF(PSC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Principal U.S. Small-Cap Multi-Factor ETF,PSC,Principal U.S. Small-Cap Multi-Factor ETF股票,Principal U.S. Small-Cap Multi-Factor ETF股票老虎,Principal U.S. Small-Cap Multi-Factor ETF股票老虎国际,Principal U.S. Small-Cap Multi-Factor ETF行情,Principal U.S. Small-Cap Multi-Factor ETF股票行情,Principal U.S. Small-Cap Multi-Factor ETF股价,Principal U.S. Small-Cap Multi-Factor ETF股市,Principal U.S. Small-Cap Multi-Factor ETF股票价格,Principal U.S. Small-Cap Multi-Factor ETF股票交易,Principal U.S. Small-Cap Multi-Factor ETF股票购买,Principal U.S. Small-Cap Multi-Factor ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Principal U.S. Small-Cap Multi-Factor ETF(PSC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Principal U.S. Small-Cap Multi-Factor ETF(PSC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}